Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;48(9):300060520957554.
doi: 10.1177/0300060520957554.

Dexmedetomidine is superior to midazolam for sedation and cerebral protection in postoperative hypertensive intracerebral hemorrhage patients: a retrospective study

Weiyi Gong  1 , Shuguang Zhang  1 , Xiaoliang Li  1 , Lei Shi  1
Affiliations

Dexmedetomidine is superior to midazolam for sedation and cerebral protection in postoperative hypertensive intracerebral hemorrhage patients: a retrospective study

Weiyi Gong et al. J Int Med Res. 2020 Sep.

Abstract

Objective: Dexmedetomidine has a good sedative effect and does not affect the judgment of the patient's consciousness level. However, its effectiveness for sedation and cerebral protection after craniotomy in hypertensive intracerebral hemorrhage (HICH) patients is unknown.

Methods: A retrospective study of 164 postoperative HICH patients who underwent sedation with dexmedetomidine or midazolam was conducted. The Ramsay sedation score, mean arterial pressure (MAP), heart rate (HR), pulse oxygen saturation (SpO2), and respiratory rate were measured at the indicated time points. Human soluble protein-100β (S-100β) and neuron-specific enolase (NSE) levels were also compared between the two groups.

Results: Dexmedetomidine treatment showed a significantly better effect than midazolam on decreasing the frequency of apparent agitation. The MAP and HR, but not the SpO2, were significantly decreased and lower than those in midazolam group. Detection of plasma S-100β and NSE proteins revealed a significant decrease in the dexmedetomidine group compared with the midazolam group. The 6-month follow-up evaluation indicated a significantly better prognosis of postoperative HICH patients treated with dexmedetomidine than for those treated with midazolam.

Conclusions: Dexmedetomidine is effective for sedation in postoperative HICH patients and may be beneficial for their outcome.

Keywords: Dexmedetomidine; cerebral protection; hypertensive intracerebral hemorrhage; midazolam; prognosis; sedation.

PubMed Disclaimer

References

    1. Xu X, Zheng Y, Chen X, et al. Comparison of endoscopic evacuation, stereotactic aspiration and craniotomy for the treatment of supratentorial hypertensive intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials 2017; 18: 296. - PMC - PubMed
    1. Muhammad S, Güresir Á, Greschus S, et al. Posterior reversible encephalopathy syndrome as an overlooked complication of induced hypertension for cerebral vasospasm: systematic review and illustrative case. Stroke 2016; 47: 519–522. - PubMed
    1. Naganuma T, Takemoto Y. New aspects of cerebrovascular diseases in dialysis patients. Contrib Nephrol 2015; 185: 138–146. - PubMed
    1. Lin B, Yang H, Cui M, et al. Surgicel™ application in intracranial hemorrhage surgery contributed to giant-cell granuloma in a patient with hypertension: case report and review of the literature. World J Surg Oncol 2014; 12: 101. - PMC - PubMed
    1. Ziliene V. Antihypertensive management in acute cerebral stroke. Medicina (Kaunas) 2005; 41: 81–88. - PubMed

MeSH terms

LinkOut - more resources